Topic: Vinay Prasad

The FDA, under Dr. Vinay Prasad, is reportedly moving away from "immunobridging" studies for vaccine approvals, requiring more rigorous outcome data. This change is linked to revelations of pediatric deaths following COVID-19 vaccinations. Simultaneously, a new actuarial study from Germany published on NIH.gov shows a strong correlation between high vaccination rates and excess mortality in the third year of the pandemic, a topic largely ignored by mainstream media.

The FDA has issued an updated safety label warning for mRNA COVID-19 vaccines regarding the risk of myocarditis and pericarditis. Data from 2023-2024 shows a rate of 27 cases per million in young men aged 12 to 24. The warning is based on persistent cardiac MRI findings and data from the BEST observational system.